2004S-0233 - Solicitation of Comments on Stimulating Innovation in Medical Technologies
  


  

  


  

  
FDA Comment Number : 
  

  
EC8
  



  

  

  



  

  
Submitter : 
  

  
Ms. Deborah Walter
  

  
Date & Time: 
  

  
09/14/2004 06:09:43
  



  

  
Organization : 
  

  
Association of Community Cancer Centers
  



  

  
Health Care Association
  


  

  
Category : 
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
Please see attached
  


  

  



  

  
Questions
  


  

  



  

  
1.  What strategies and approaches could HHS implement to accelerate the development and application of new medical technologies?
  


  

  



  

  
Please see attached
  


  

  



  

  
 2. How can HHS help its agencies (e.g., NIH (and its grantees), FDA, CDC, and CMS) to work together more effectively to eliminate obstacles to development of medical technologies?

  


  

  


  

  


  

  
Please see attached
  


  

  



  

  
3. How can the HHS scientific and regulatory agencies work more effectively with CMS to eliminate obstacles to development?
  


  

  



  

  
Please see attached
  


  

  



  

  
4. What forums should HHS use to survey constituents about obstacles in innovation (e.g., public meetings, contract research, focus groups)?
  


  

  



  

  
Please see attached
  


  

  


  

  
5. How can the portability of informaion between HHS agencies be optimized?
  


  

  



  

  
Please see attached
  


  

  



  

  
6. Which HHS policies and programs effectively spur innovation?
  


  

  



  

  
Please see attached